Goldman Sachs’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Goldman Sachs’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200,000	Closed	-$2.06M	–	6276
2023 Q1	$2.06M	Sell	200,000 -2,134	-1%	-$21.9K	﹤0.01%	3842
2022 Q4	$2.08M	Hold	202,134	–	–	﹤0.01%	3915
2022 Q3	$2.04M	Hold	202,134	–	–	﹤0.01%	3960
2022 Q2	$2.02M	Hold	202,134	–	–	﹤0.01%	4038
2022 Q1	$2.02M	Buy	+202,134	New	+$2.01M	﹤0.01%	4251

Goldman Sachs's IQMD Position: Q2 2023 in Review

Goldman Sachs sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 200,000 shares — an estimated $2.06M sold.

Goldman Sachs first reported a position in IQMD in Q1 2022 and held it in 5 quarters. The position peaked at $2.08M in Q4 2022. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Goldman Sachs reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 200,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.06M.
Goldman Sachs first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Goldman Sachs's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.08M in Q4 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.